Published in:

01-02-2009 | Original Article

Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy

First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial

Authors: Gregor Goldner, MD, Valentin Bombosch, Hans Geinitz, Gerd Becker, Stefan Wachter, Stefan Glocker, Frank Zimmermann, Natascha Wachter-Gerstner, Andrea Schrott, Michael Bamberg, Michael Molls, Horst Feldmann, Richard Pötter

Published in: Strahlentherapie und Onkologie | Issue 2/2009